Articles by Niels van de Donk, MD, PhD
The study evaluated teclistamab in patients with relapsed or refractory multiple myeloma.
The LocoMMotion study provides real-world data on outcomes in triple-class exposed MM patients receiving standard of care.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.